famili
coronavirida
harbor
envelop
positivesens
rna
virus
infect
mammal
bird
sever
coronavirus
cov
within
genera
alphacoronaviru
betacoronaviru
constantli
circul
human
popul
caus
mild
respiratori
diseas
addit
betacoronavirus
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
cov
zoonot
transmit
anim
human
camel
serv
natur
reservoir
merscov
infect
anim
may
exhibit
mild
respiratori
symptom
contrast
transmiss
merscov
human
induc
fatal
diseas
afflict
patient
mer
case
document
middl
east
viru
introduc
sever
countri
due
intern
travel
present
humantohuman
transmiss
merscov
ineffici
howev
massiv
mer
outbreak
observ
hospit
set
instanc
introduct
merscov
republ
korea
singl
infect
travel
result
infect
includ
secondari
tertiari
quaternari
case
death
whether
viru
respons
korean
outbreak
harbor
mutat
promot
human
human
spread
incomplet
understood
infecti
entri
merscov
target
cell
mediat
viral
spike
glycoprotein
merss
incorpor
viral
envelop
merss
contain
surfac
unit
transmembran
unit
subunit
bind
main
receptor
secondari
receptor
sialic
acid
subunit
facilit
fusion
viral
envelop
cellular
membran
membran
fusion
depend
prior
proteolyt
cleavag
activ
inact
protein
precursor
host
cell
proteas
specif
endosom
cystein
proteas
cathepsin
l
catl
type
ii
transmembran
serin
proteas
locat
plasma
membran
activ
merss
sequenc
analysi
reveal
merscov
variant
observ
korean
outbreak
contain
polymorph
respect
viral
variant
transmit
patient
polymorph
locat
receptor
bind
domain
rbd
fig
portion
requir
bind
one
specul
might
increas
viral
fit
andor
transmiss
howev
counterintuit
shown
decreas
bind
shown
decreas
merssdriven
entri
cell
present
unknown
whether
viru
benefit
chang
show
sever
paramet
control
effici
merssdriven
entri
includ
sialic
acid
engag
blockad
interferon
ifn
induc
transmembran
protein
ifitm
modul
moreov
confirm
reduc
bind
show
translat
reduc
entri
small
amount
express
final
demonstr
reduc
sensit
antibodymedi
neutral
suggest
mutat
might
alter
viral
transmiss
might
increas
viral
spread
infect
patient
presenc
antibodi
respons
first
investig
whether
polymorph
identifi
korean
mer
outbreak
fig
compat
robust
protein
express
proteindriven
host
cell
entri
comparison
analyz
polymorph
found
merss
virus
arabian
peninsula
fig
chang
previous
investig
impact
merssdriven
entri
analys
merssmedi
entri
employ
previous
describ
vesicular
stomat
viru
vsv
base
pseudotyp
system
faith
mimic
central
aspect
merscov
entri
target
cell
analysi
cell
transfect
express
protein
studi
follow
immunoblot
signal
quantif
reveal
wildtyp
wt
merss
protein
variant
compar
express
fig
similarli
protein
proteolyt
process
fig
top
agreement
find
furin
process
protein
mersstransfect
merscovinfect
cell
final
protein
mutant
effici
incorpor
vsv
particl
although
incorpor
mutant
slightli
reduc
compar
merss
wt
fig
thu
polymorph
studi
impact
protein
express
proteolyt
process
except
mutant
incorpor
vsv
particl
next
analyz
whether
polymorph
impact
entri
colonderiv
cell
line
african
green
monkey
kidney
cell
line
vero
human
adren
glandderiv
cell
line
either
control
transfect
transfect
express
plasmid
cell
line
chosen
analysi
permiss
merscov
infect
previous
use
studi
host
cell
interact
merscov
select
cell
line
highli
permiss
transduct
rhabdovir
particl
harbor
vsv
glycoprotein
vsvg
posit
control
transduct
particl
bear
glycoprotein
neg
control
within
background
level
expect
fig
chang
observ
merscov
human
camel
middl
east
effect
transduct
effici
contrast
chang
lesser
degre
observ
korean
mer
patient
reduc
entri
vero
cell
fig
diminish
bind
fig
agreement
publish
data
howev
mutat
modest
effect
transduct
cell
express
satur
amount
respect
fig
data
shown
find
direct
express
could
larg
rescu
inhibitori
effect
transduct
cell
prompt
us
investig
whether
impact
chang
proteindriven
entri
depend
level
express
inde
quantit
revers
transcriptionpcr
fig
flow
cytometri
fig
reveal
cell
readili
transduc
merss
variant
express
substanti
higher
level
vero
cell
readili
suscept
transduct
mediat
protein
mutant
fig
collect
result
confirm
reduc
protein
bind
also
suggest
reduct
translat
diminish
proteindriven
cell
entri
express
low
recent
studi
show
merss
bind
sialic
acid
glycan
present
plasma
membran
protein
lipid
sialic
acid
engag
promot
proteindriven
entri
enzymat
remov
sialic
acid
neuraminidas
na
treatment
investig
whether
korean
polymorph
polymorph
found
middl
east
impact
sialic
acid
depend
neuraminidas
treatment
markedli
reduc
influenza
viru
hemagglutinin
ha
driven
entri
effect
entri
driven
vsvg
fig
expect
moreov
entri
driven
merss
wt
protein
variant
compar
inhibit
neuraminidas
treatment
fig
indic
none
amino
acid
chang
merss
alter
sialic
acid
depend
viral
entri
catl
activ
merss
cell
cultur
activ
relat
enzym
requir
sarscov
spread
host
therefor
investig
whether
polymorph
studi
modul
capac
merss
employ
catl
activ
first
employ
cell
express
endogen
catl
allow
merssdriven
entri
catldepend
fashion
cell
transfect
plasmid
either
encod
empti
plasmid
control
incub
catl
inhibitor
analyz
proteindriven
transduct
incub
control
cell
reduc
entri
driven
merss
wt
protein
variant
effect
fulli
rescu
direct
express
fig
next
investig
protein
activ
cell
express
endogen
afford
opportun
visual
potenti
subtl
impact
protein
polymorph
activ
howev
incub
cell
rise
concentr
camostat
mesyl
inhibitor
compar
reduc
entri
driven
merss
wt
protein
variant
effect
vsvgmediat
entri
fig
expect
find
suggest
polymorph
studi
compromis
protein
activ
catl
endow
protein
abil
use
low
level
activ
increas
effici
protein
activ
express
ifitm
protein
ifn
induc
inhibit
merssdriven
entri
target
cell
like
stage
membran
fusion
investig
whether
protein
polymorph
studi
modul
suscept
merssdriven
entri
blockad
ifitm
protein
employ
cell
stabli
express
express
ifitm
protein
littl
effect
entri
driven
machupo
viru
glycoprotein
macvgpc
markedli
reduc
entri
influenza
viru
hemagglutinin
fig
accord
publish
data
moreov
express
diminish
merss
wtmediat
host
cell
entri
expect
similar
effect
observ
protein
variant
analyz
fig
final
compar
result
obtain
cell
transient
transfect
escal
amount
plasmid
although
variant
show
slightli
reduc
sensit
condit
data
shown
sum
rbd
polymorph
observ
korean
patient
merscov
middl
east
markedli
alter
ifitm
sensit
viral
entri
antibodi
respons
significantli
contribut
control
merscov
infect
host
therefor
ask
whether
polymorph
studi
impact
antibodymedi
neutral
focus
analysi
sinc
chang
modul
effici
host
cell
entri
first
test
whether
alter
inhibit
proteindriven
entri
murin
antibodi
bind
epitop
encompass
amino
acid
macaqu
antibodi
recogn
epitop
includ
amino
acid
inde
exchang
render
merssdriven
entri
insensit
inhibit
reduc
blockad
proteindriven
entri
fig
find
encourag
us
investig
whether
alter
suscept
merssdriven
host
cell
entri
inhibit
human
sera
obtain
mer
patient
studi
sera
three
patient
acquir
merscov
infect
middl
east
admit
german
hospit
essen
serum
munich
tabl
one
serum
sampl
suffici
quantiti
detail
analysi
other
could
test
singl
dilut
remark
merss
harbor
polymorph
show
significantli
increas
resist
neutral
one
serum
sampl
polymorph
diminish
neutral
two
sera
fig
c
final
neither
mutat
impact
neutral
serum
sampl
howev
overal
neutral
activ
particular
serum
sampl
reduc
compar
sera
test
might
low
allow
differenti
neutral
merss
wt
mutant
summari
result
suggest
increas
resist
humor
immun
respons
might
driven
emerg
variant
larg
mer
outbreak
within
hospit
republ
korea
rais
question
whether
viral
variant
increas
transmiss
might
respons
inde
major
patient
korea
harbor
virus
least
one
uniqu
mutat
rbd
andor
unexpectedli
mutat
reduc
bind
viral
entri
rais
question
whether
benefici
viru
found
compat
robust
proteindriven
entri
cell
express
larg
amount
confer
resist
antibodymedi
neutral
find
support
previous
propos
concept
escap
antibodi
respons
might
shape
merscov
evolut
might
come
cost
reduc
bind
howev
also
suggest
diminish
bind
may
compromis
abil
merscov
spread
target
cell
express
robust
level
mer
outbreak
republ
korea
initi
singl
infect
travel
compris
case
death
encompass
primari
secondari
tertiari
quaternari
infect
casefat
rate
roughli
thu
lower
report
mer
patient
middl
east
may
variou
reason
includ
differ
patient
care
virul
merscov
strain
respons
outbreak
mutat
detect
patient
korea
examin
one
studi
might
alreadi
present
index
patient
similarli
protein
sequenc
patient
deposit
viru
variat
databas
http
wwwncbinlmnihgovgenomevirusesvari
contain
chang
moreov
virus
harbor
mutat
establish
secondari
tertiari
quaternari
infect
contrast
mutat
present
patient
analyz
previou
studi
protein
sequenc
deposit
viru
variat
databas
contain
exchang
kim
colleagu
report
particularli
diminish
bind
merss
reduc
entri
cell
transfect
express
moreov
structur
evid
mutat
disturb
interfac
merss
present
howev
remain
unclear
whether
mutat
may
also
aid
viru
spread
certain
condit
bind
merss
essenti
infecti
host
cell
entri
protein
interact
import
determin
merscov
speci
tropism
moreov
patient
chronic
lung
diseas
shown
express
increas
level
known
augment
risk
develop
fatal
mer
suggest
level
express
physiolog
condit
might
limit
viral
spread
patient
therefor
investig
whether
previous
report
neg
effect
merssdriven
entri
depend
express
level
result
show
inde
case
mutat
markedli
reduc
entri
cell
express
low
level
endogen
mrna
protein
littl
effect
entri
cell
express
larg
amount
robust
express
detect
viral
target
cell
human
respiratori
epithelium
type
type
ii
pneumocyt
alveolar
macrophag
thu
conceiv
wt
viru
viru
bear
infect
cell
compar
effici
lung
mer
patient
final
one
specul
engag
attachmentpromot
factor
express
viral
target
cell
human
respiratori
tract
cell
line
studi
might
allow
mutant
compens
reduc
bind
enter
cell
effici
wt
viru
proteolyt
activ
merss
host
cell
proteas
essenti
merssdriven
entri
target
cell
therefor
address
whether
might
augment
viral
spread
promot
protein
activ
chang
choic
proteinactiv
proteas
two
interconnect
rout
describ
merss
activ
upon
bind
either
viru
may
transport
host
cell
endosom
protein
activ
cathepsin
l
protein
may
activ
cell
surfac
notabl
choic
catl
might
determin
protein
process
infect
cell
protein
cleavag
furin
infect
cell
seem
indispens
subsequ
conform
chang
protein
turn
essenti
activ
present
studi
demonstr
impact
neither
protein
cleavag
furin
protein
activ
catl
find
may
unexpect
sinc
residu
locat
distant
two
site
believ
import
protein
process
activ
site
site
sever
cellular
factor
modul
effici
merssdriven
entri
cell
rais
question
whether
might
alter
effect
way
promot
viral
spread
ligand
adenosin
deaminas
highli
express
lymphoid
tissu
constitut
compon
purin
salvag
pathway
shown
compet
merss
bind
block
merssdriven
entri
target
cell
moreov
ifninduc
transmembran
protein
lesser
degre
demonstr
block
merssdriven
entri
least
upon
overexpress
final
merss
shown
bind
coreceptor
sialic
acid
promot
viral
entri
target
cell
result
indic
impact
abovenam
process
suggest
mutat
might
affect
neither
viral
attach
cell
membran
fusion
reaction
spike
protein
key
target
neutral
antibodi
antibodi
detect
high
frequenc
convalesc
mer
patient
surviv
sever
diseas
neutral
antibodi
direct
rbd
interfer
viral
entri
block
protein
interact
previou
studi
conduct
cell
cultur
system
found
merscov
acquir
mutat
allow
escap
rbdtarget
neutral
antibodi
also
provid
evid
mutat
might
come
cost
decreas
bind
viral
fit
scenario
gener
match
find
render
protein
least
partial
resist
neutral
monoclon
antibodi
sera
mer
patient
reduc
bind
howev
result
also
allow
specul
reduc
bind
might
necessarili
translat
reduc
viral
spread
host
cell
express
high
level
possibl
await
confirm
infecti
merscov
primari
target
cell
nevertheless
would
keep
observ
virus
harbor
chang
robustli
transmit
patient
mer
outbreak
republ
korea
although
chang
provid
viru
advantag
absenc
humor
respons
final
find
singl
point
mutat
merss
increas
resist
antibodymedi
neutral
highlight
need
develop
vaccin
therapeut
simultan
target
multipl
epitop
merss
collect
find
previou
work
suggest
merscov
variant
least
partial
resist
antibodymedi
neutral
retain
high
infect
cell
express
robust
amount
spread
human
employ
express
plasmid
encod
vsv
glycoprotein
vsvg
machupo
viru
glycoprotein
macvgpc
kindli
provid
farzan
influenza
viru
strain
hemagglutinin
neuraminidas
wsnhana
wt
merss
describ
elsewher
addit
employ
overlap
extens
pcr
gener
merss
mutant
harbor
singl
mutat
rbd
primer
sequenc
detail
inform
clone
procedur
avail
upon
request
protein
also
gener
version
contain
ctermin
epitop
detect
immunoblot
express
plasmid
ntermin
fuse
cmyc
epitop
ntermin
fuse
dsred
construct
amplifi
genet
inform
exist
express
plasmid
clone
respect
open
read
frame
orf
pqcxip
plasmid
kindli
provid
l
brass
express
vector
exchang
select
marker
puromycin
resist
blasticidin
resist
taken
plasmid
vector
pcramplifi
sequenc
subject
autom
sequenc
analysi
microsynth
seqlab
verifi
integr
human
vero
african
green
monkey
cell
cultiv
dulbecco
modifi
eagl
medium
dmem
panbiotech
addit
human
colorect
adenocarcinoma
cell
line
grown
minimum
essenti
medium
mem
thermo
fisher
scientif
cell
stabli
express
ifitm
chloramphenicol
acetyltransferas
cat
cultiv
parent
cell
line
except
addit
receiv
puromycin
biomol
media
supplement
fetal
bovin
serum
fb
panbiotech
well
penicillin
streptomycin
stock
solut
panbiotech
cell
line
cultiv
humidifi
atmospher
transfect
cell
perform
calcium
phosphat
precipit
employ
inhibitor
target
cathepsin
l
relat
proteas
sigmaaldrich
relat
proteas
camostat
mesyl
sigmaaldrich
target
cell
transduct
experi
treat
respect
inhibitor
specif
concentr
indic
legend
respect
figur
h
prior
inocul
rhabdovir
transduct
vector
remov
termin
sialic
acid
macromolecul
cell
surfac
target
cell
preincub
mu
recombin
neuraminidas
sigmaaldrich
h
inocul
rhabdovir
transduct
vector
employ
rhabdovir
transduct
vector
pseudoparticlespseudotyp
base
replicationdefici
vesicular
stomat
viru
lack
genet
inform
vsvg
contain
orf
enhanc
green
fluoresc
protein
egfp
firefli
luciferas
fluc
vsv
product
vsvbase
pseudotyp
vsvpp
cell
transfect
express
plasmid
merss
wt
mutant
merss
harbor
rbd
polymorph
macvgpc
wsn
hana
vsvg
posit
control
empti
express
vector
neg
control
h
posttransfect
cell
inocul
vsvgtranscompl
vsv
indiana
strain
kindli
provid
g
zimmer
multipl
infect
incub
h
next
inoculum
remov
cell
wash
phosphatebuff
salin
pb
standard
cultur
medium
contain
antivsvg
antibodi
mous
hybridoma
supernat
atcc
ad
neutral
residu
input
viru
cell
transfect
vsvg
express
plasmid
receiv
cultur
medium
without
antivsvg
antibodi
cell
incub
h
supernat
harvest
freed
cellular
debri
centrifug
g
min
either
store
use
transduct
experi
latter
target
cell
grown
plate
necessari
target
cell
previous
transfect
express
plasmid
andor
h
advanc
pretreat
proteas
inhibitor
neuraminidas
h
advanc
transduct
cultur
medium
aspir
rhabdovir
transduct
vector
ad
cell
transduct
effici
quantifi
measur
virusencod
fluc
activ
cell
lysat
use
commerci
kit
beetl
juic
pjk
plate
luminomet
hidex
turku
finland
describ
elsewher
cell
transfect
express
plasmid
ctermin
version
merss
wt
merss
mutant
control
transfect
empti
plasmid
neg
control
h
posttransfect
cultur
supernat
remov
cell
wash
pb
whole
cell
lysat
wcl
prepar
follow
first
sampl
buffer
trishcl
glycerol
sd
betamercaptoethanol
bromophenol
blue
mm
edta
ad
cell
incub
min
sampl
transfer
reaction
tube
heat
addit
min
analysi
protein
incorpor
vsv
particl
respect
cultur
supernat
pellet
highspe
centrifug
g
min
wtvol
sucros
cushion
mix
sd
sampl
buffer
heat
addit
min
follow
sdspage
protein
transfer
onto
nitrocellulos
membran
hartenstein
gmbh
immunoblot
membran
block
incub
skim
milk
tween
pbst
min
room
temperatur
rt
incub
primari
antibodi
solut
antiactb
antivsvm
overnight
next
membran
wash
pbst
incub
secondari
antibodi
solut
antimousehorseradish
peroxidas
hrp
h
rt
addit
wash
step
membran
final
develop
use
housemad
chemiluminesc
reagent
combin
chemocam
imag
system
chemostar
profession
softwar
inta
scienc
imag
instrument
gmbh
quantif
signal
intens
program
imagej
fiji
distribut
use
protein
signal
detect
wcl
supernat
normal
respect
signal
load
control
either
actb
vsvm
follow
antibodi
use
primari
antibodi
mous
thermo
fisher
scientif
actb
mous
sigmaaldrich
antivsvm
mous
kerafast
secondari
antibodi
hrpcoupl
antimous
antibodi
use
goat
dianova
antibodi
dilut
pbst
carl
roth
skim
milk
carl
roth
detect
interact
cell
transfect
express
plasmid
merss
wt
merss
mutant
vsvg
empti
plasmid
neg
control
h
posttransfect
cell
wash
pb
resuspend
bovin
serum
albumin
bsa
pb
next
cell
pellet
centrifug
min
g
resuspend
bsapb
contain
solubl
equip
ctermin
human
fc
tag
acrobiosystem
incub
h
cell
wash
bsapb
resuspend
bsapb
contain
alexa
fluor
antihuman
antibodi
thermo
fisher
scientif
anoth
incub
period
describ
cell
wash
bsapb
fix
paraformaldehyd
solut
analyz
flow
cytometri
describ
analysi
surfac
express
flow
cytometri
untransfect
transfect
express
plasmid
vero
cell
detach
resuspens
bsapb
cell
incub
citric
salin
pb
contain
potassium
chlorid
sodium
citrat
vero
cell
cell
pellet
wash
describ
success
incub
mous
abcam
alexa
fluor
antimous
goat
thermo
fisher
scientif
antibodi
fix
final
sampl
analyz
use
lsr
ii
flow
cytomet
fac
diva
softwar
bd
bioscienc
data
analysi
fc
express
flow
research
softwar
de
novo
softwar
employ
total
cellular
rna
extract
vero
cell
use
rneasi
minikit
qiagen
accord
manufactur
instruct
rna
treat
dnase
new
england
biolab
revers
transcrib
cdna
use
superscript
iii
firststrand
synthesi
system
thermo
fisher
scientif
follow
manufactur
specif
subsequ
sampl
subject
quantit
pcr
qpcr
use
quantitect
sybr
green
pcr
kit
qiagen
rotorgen
q
platform
qiagen
sampl
analyz
housekeep
gene
control
gene
interest
transcript
triplic
final
data
analyz
base
threshold
cycl
method
use
cell
refer
rhabdovir
transduct
vector
harbor
merss
wt
merss
mutant
vsvg
normal
compar
transduct
cell
luminesc
countss
incub
min
rt
increas
concentr
monoclon
antibodi
target
distinct
epitop
within
merss
rbd
target
epitop
around
amino
acid
residu
merss
isol
vaccin
nonhuman
primat
pdb
code
target
epitop
around
amino
acid
residu
merss
isol
vaccin
mice
differ
dilut
serum
mer
patient
travel
arabian
peninsula
germani
furthermor
sera
two
addit
mer
patient
test
dilut
sinc
amount
sera
limit
test
fix
dilut
pleas
see
tabl
inform
sera
patient
histori
afterward
mixtur
vsvpp
antibodiesserum
inocul
onto
cell
incub
h
posttransduct
transduct
effici
quantifi
describ
normal
transduct
effici
rhabdovir
transduct
vector
incub
absenc
antibodiesserum
set
state
otherwis
unpair
pair
twotail
student
test
perform
test
statist
signific
data
origin
singl
repres
multipl
combin
experi
respect
figur
statist
signific
repres
follow
p
p
p
ns
signific
